Search results
Results from the WOW.Com Content Network
Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops, and commercializes drugs. The company focuses primarily on drugs used in the treatment of thrombosis and hematological malignancies . [ 2 ]
Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. [1] It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
A. Abbott Laboratories; AbbVie; Acadia Pharmaceuticals; Acceleron Pharma; Acorda Therapeutics; ACT Biotech Inc; Acura Pharmaceuticals; Aerie Pharmaceuticals; Agios ...
A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Foresite Capital funded 10x Genomics since its Series A round in November 2013 and led its Series B round in January 2015, as well as its Series C round in March 2016. [13] [14] Foresite Capital has invested in companies such as Acceleron Pharma, Aimmune, Alumis, ALX Oncology, Aerie Pharmaceuticals, [15] Ascendis, Blueprint Medicines, CG Oncology, Color Genomics, Cue Health, Cytokinetics ...
On Thursday, Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study of navacaprant for major depressive disorder. The KOASTAL ...